Advamed pushes for medical device exemption from Trump tariffs

CEO Scott Whitaker said “an exemption was provided for most medical devices during President Trump’s first term with respect to the tariffs on China, and we are advocating for a similar approach.”

By Susan Kelly • Feb. 3, 2025

Baxter CEO José Almeida retires

Brent Shafer, Baxter’s lead independent director, will serve as interim CEO. The company also promoted Heather Knight to chief operating officer.

By Elise Reuter • Feb. 3, 2025

Explore the Trendline➔

Medical device safety in spotlight after high profile recalls

From Philips’ massive recall of respiratory devices to ongoing health risks with breast implants, medical devices tied to patient harm have put a focus on product safety.

By MedTech Dive staff

Trump issues tariffs on Canada, Mexico and China

The president ordered an additional 10% duty on goods from China and 25% tariffs on imports from Canada and Mexico, though Canadian energy resources will face a lower rate.

By Philip Neuffer • Updated Feb. 1, 2025

Troy Tazbaz, CDRH digital health leader, resigns

Tazbaz was director of the FDA’s Digital Health Center of Excellence for two years, leading key policies on artificial intelligence and software as a medical device.

By Elise Reuter • Jan. 31, 2025

Top medtech trends in 2025: New products and M&A are bright spots, but Trump brings uncertainty

Experts highlighted surgical robotics, artificial intelligence and M&A as top trends this year. However, the Trump administration could create challenges for the industry.

By Ricky Zipp • Jan. 31, 2025

Beta Bionics raises $204M in IPO

The diabetes tech firm began trading this week and was valued at $966.2 million as of Thursday.

By Elise Reuter • Jan. 31, 2025

FDA warns about patient monitor cybersecurity vulnerabilities

Vulnerabilities in certain Contec and Epsimed patient monitors can allow people to gain access and potentially manipulate the devices, the FDA warned.

By Nick Paul Taylor • Jan. 31, 2025

Getinge exits surgical perfusion, creating opportunity for Livanova

Getinge CEO Mattias Perjos said surgical perfusion has “been a struggling category” since an FDA consent decree forced the company off the U.S. market in 2015.

By Nick Paul Taylor • Jan. 30, 2025

White House rescinds memo pausing federal funding following pushback

The Office of Management and Budget rolled back a memo halting federal funding that caused widespread confusion and alarm. But “this is NOT a rescission of the federal funding freeze,” Trump’s top press secretary said.

By Rebecca Pifer • Jan. 29, 2025

Stryker to sell spinal implants business

The company named a new CFO and shared an update on its planned Inari Medical acquisition.

By Elise Reuter • Jan. 29, 2025

4 robotic surgery trends to watch in 2025

Intuitive Surgical will face competition this year from Medtronic and smaller companies like CMR Surgical and Moon Surgical coming to the U.S. market with robotic surgery systems.

By Susan Kelly • Jan. 29, 2025

Lawmakers report states shut out of Medicaid payment portals following Trump funding freeze

Other payment systems also appear to be offline, suggesting a broader shutdown of federal portals related to grants and funding.

By Rebecca Pifer • Updated Jan. 28, 2025

Trump freezes federal grants with big potential impact on providers, Medicaid

Federal agencies must stop disbursing financial assistance starting at 5 p.m. today under a new budget directive, threatening funding for providers and creating significant uncertainty for Medicaid payments to states.

By Rebecca Pifer • Jan. 28, 2025

Philips to sell emergency care business

Investment firm Bridgefield Capital will buy the segment, which includes cardiac resuscitation and emergency care devices, for an undisclosed amount.

By Elise Reuter • Jan. 28, 2025

Neko Health raises $260M to expand body scan service, fund R&D

The company uses various medical devices to noninvasively check moles, the heart and more.

By Nick Paul Taylor • Jan. 28, 2025

FDA webpages on clinical trial diversity removed after Trump orders

The website changes raise concerns about “the interference of politics with the study and the practice” of science and medicine, a physician said.

By Elise Reuter • Jan. 27, 2025

Doctors expect Boston Scientific to lead PFA race, survey finds

Physicians also expect greater use of Johnson & Johnson’s Varipulse system over the next two years despite the company’s current pause of U.S. cases, according to a poll by BTIG.

By Susan Kelly • Jan. 27, 2025

Sara Brenner named acting FDA commissioner

Brenner, who worked in the FDA’s Center for Devices and Radiological Health, will take the helm of the agency until a new leader is confirmed.

By Elise Reuter • Jan. 24, 2025

Intuitive execs cast wary eye on potential Trump tariffs

The surgical robot leader is watching developments under the new administration but has not included any tariff impact in its financial forecast.

By Susan Kelly • Jan. 24, 2025

Medtronic links closed-loop pain device to improvements after 12 months

The Inceptiv data give Medtronic more evidence as it tries to increase sales of a product that drove double-digit growth at the company’s pain stimulation unit last quarter.

By Nick Paul Taylor • Jan. 24, 2025

Senate sets date to vet RFK Jr.’s nomination to lead HHS

The Senate Finance Committee will meet on Jan. 29 to discuss the confirmation of RFK Jr., whose stances on vaccines and abortion have raised questions from Democrats and Republicans alike.  

By Kristin Jensen • Jan. 23, 2025

Intuitive inks deals to sell robots in Italy, Spain and Portugal

Intuitive is buying businesses that distribute its da Vinci and Ion surgical robots to establish a direct presence in Italy, Spain, Portugal, Malta and San Marino.

By Nick Paul Taylor • Jan. 23, 2025

Trump eyes 10% China tariff hike by Feb. 1

The president floated a similar timeline for 25% tariffs on Canada and Mexico.

By Philip Neuffer • Jan. 23, 2025

Abbott expects to launch first PFA device outside of the US this year

CEO Robert Ford also plans to expand sales of the company’s Lingo over-the-counter glucose sensors after a limited rollout.

By Elise Reuter • Jan. 22, 2025

Masimo picks Katie Szyman as CEO

Szyman led Edwards Lifesciences’ critical care unit for more than a decade before BD acquired the group last year. Her appointment “fits like a glove,” BTIG analyst Marie Thibault wrote.

By Susan Kelly • Jan. 22, 2025